Clinical trial
Comparison of IPX054 and Immediate-Release Carbidopa-Levodopa in Patients With…
NCT00253084 · Impax Laboratories, LLC, Industry · Completed
Key facts
| NCT number | NCT00253084 |
|---|---|
| Title | Comparison of IPX054 and Immediate-Release Carbidopa-Levodopa in Patients With Parkinson's Disease |
| Official title | A Randomized, Double-Blind, Cross-Over Study to Compare IPX054 to Carbidopa-Levodopa Immediate-Release Tablets in Subjects With Parkinson's Disease |
| Lead sponsor | Impax Laboratories, LLC, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Parkinson's Disease |
| Intervention type | Drug |
| Interventions | IPX054 200 mg, CD-LD IR, IPX054 Placebo, CD-LD IR Placebo |
| Enrollment | 12 |
| Start date | Nov 1, 2005 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Nov 15, 2005 |
| Last update posted | Oct 29, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: